5-aminoimidazole-4-carboxamide ribonucleoside and AMP-activated protein kinase inhibit signalling through NF-B

Immunology and Cell Biology

Volumn 88, Issue 7, 2010, Pages 754-760

  Katerelos, Marina ^a,b   Mudge, Stuart J ^a   Stapleton, David ^c   Auwardt, Russell B ^a   Fraser, Scott A ^a,b   Chen, C G ^d   Kemp, Bruce E ^e   Power, David A ^a,b  

^a AUSTIN HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d CSL LIMITED   (Australia)

^e ST VINCENT S HOSPITAL   (Australia)

Author keywords

AICAR; AMP activated protein kinase; BAEC; NF B

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHOTREXATE; OLIGONUCLEOTIDE; SALAZOSULFAPYRIDINE;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DNA BINDING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION;

AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTI-INFLAMMATORY AGENTS; CATTLE; CELLS, CULTURED; DNA-BINDING PROTEINS; ENDOTHELIAL CELLS; ENZYME ACTIVATION; HELA CELLS; HUMANS; MESANGIAL CELLS; NF-KAPPA B; PHENFORMIN; PROLINE; RATS; RIBONUCLEOTIDES; THIOCARBAMATES;

BOVINAE;

EID: 77956695619     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.44     Document Type: Article

References (41)

1. Hardie DG, Carling D. The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur J Biochem 1997; 246: 259-273.
2. Kemp BE, Mitchelhill KI, Stapleton D, Michell BJ, Chen ZP, Witters LA. Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci 1999; 24: 22-25.
3. Steinberg GR. Role of the AMP-activated protein kinase in regulating fatty acid metabolism during exercise. Appl Physiol Nutr Metab 2009; 34: 315-322.
4. Corton JM, Gillespie JG, Hawley SA, Hardie DG. 5-aminoimidazole-4- carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 1995; 229: 558-565.
5. Fryer LG, Hajduch E, Rencurel F, Salt IP, Hundal HS, Hardie DG et al. Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase. Diabetes 2000; 49: 1978-1985.
6. Winder WW, Hardie DG. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol 1996; 270: E299-E304.
7. Mount PF, Hill RE, Fraser SA, Levidiotis V, Katsis F, Kemp BE et al. Acute renal ischemia rapidly activates the energy sensor AMPK but does not increase phosphorylation of eNOS-Ser1177. Am J Physiol Renal Physiol 2005; 289: F1103-F1115.
8. Peairs A, Radjavi A, Davis S, Li L, Ahmed A, Giri S et al. Activation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cells. Clin Exp Immunol 2009; 156: 542-551.
9. Giri S, Nath N, Smith B, Viollet B, Singh AK, Singh I. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase. J Neurosci 2004; 24: 479-487.
10. Lenardo MJ, Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissuespecific gene control. Cell 1989; 58: 227-229.
11. Ben-Neriah Y, Schmitz ML. Of mice and men. EMBO Rep 2004; 5: 668-673.
12. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev 1995; 9: 2723-2735.
13. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995; 270: 286-290.
14. Ziegler-Heitbrock HW, Sternsdorf T, Liese J, Belohradsky B, Weber C, Wedel A et al. Pyrrolidine dithiocarbamate inhibits NF-kappa B mobilization and TNF production in human monocytes. J Immunol 1993; 151: 6986-6993.
15. Mullane K. Acadesine: the prototype adenosine regulating agent for reducing myocardial ischaemic injury. Cardiovasc Res 1993; 27: 43-47.
16. Engler RL. Harnessing nature's own cardiac defense mechanism with acadesine, an adenosine regulating agent: importance of the endothelium. J Card Surg 1994; 9: 482-492.
17. Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994; 265: 956-959.
18. Manna SK, Mukhopadhyay A, Aggarwal BB. Leflunomide suppresses TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis. J Immunol 2000; 165: 5962-5969.
19. Lindner V, Collins T. Expression of NF-kappa B and I kappa B-alpha by aortic endothelium in an arterial injury model. Am J Pathol 1996; 148: 427-438.
20. Auwardt RB, Mudge SJ, Chen CG, Power DA. Regulation of nuclear factor kappaB by corticosteroids in rat mesangial cells. J Am Soc Nephrol 1998; 9: 1620-1628.
21. Sun Y, Connors KE, Yang DQ. AICAR induces phosphorylation of AMPK in an ATMdependent, LKB1-independent manner. Mol Cell Biochem 2007; 306: 239-245.
22. Hattori Y, Akimoto K, Murakami Y, Kasai K. Pyrrolidine dithiocarbamate inhibits cytokine-induced VCAM-1 gene expression in rat cardiac myocytes. Mol Cell Biochem 1997; 177: 177-181.
23. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin Jr AS. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995; 270: 283-286.
24. Hattori Y, Suzuki K, Hattori S, Kasai K. Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension 2006; 47: 1183-1188.
25. Hattori Y, Suzuki K, Tomizawa A, Hirama N, Okayasu T, Hattori S et al. Cilostazol inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells. Cardiovasc Res 2009; 81: 133-139.
26. Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005; 310: 1642-1646.
27. Legembre P, Schickel R, Barnhart BC, Peter ME. Identification of SNF1/AMP kinaserelated kinase as an NF-kappaB-regulated anti-apoptotic kinase involved in CD95-induced motility and invasiveness. J Biol Chem 2004; 279: 46742-46747.
28. Lefebvre DL, Bai Y, Shahmolky N, Sharma M, Poon R, Drucker DJ et al. Identification and characterization of a novel sucrose-non-fermenting protein kinase/AMP-activated protein kinase-related protein kinase, SNARK. Biochem J 2001; 355: 297-305.
29. Nakai T, Kano S, Satoh K, Hoshi K, Ichihara K. Effects of adenine nucleotide analogues on myocardial dysfunction during reperfusion after ischemia in dogs. J Cardiovasc Pharmacol 1996; 28: 264-270.
30. Tsuchida A, Yang XM, Burckhartt B, Mullane KM, Cohen MV, Downey JM. Acadesine extends the window of protection afforded by ischaemic preconditioning. Cardiovasc Res 1994; 28: 379-383.
31. Koong AC, Chen EY, Mivechi NF, Denko NC, Stambrook P, Giaccia AJ. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Cancer Res 1994; 54: 5273-5279.
32. Zhong H, Su Yang H, Erdjument-Bromage H, Tempst P, Ghosh S. The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 1997; 89: 413-424.
33. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 1999; 274: 30353-30356.
34. Burlington H, Cronkite EP. Characteristics of cell cultures derived from renal glomeruli. Proc Soc Exp Biol Med 1973; 142: 143-149.
35. Booyse FM, Sedlak BJ, Rafelson Jr ME. Culture of arterial endothelial cells: characterization and growth of bovine aortic cells. Thromb Diath Haemorrh 1975; 34: 825-839.
36. Chen CG, Malliaros J, Katerelos M, d'Apice AJ, Pearse MJ. Inhibition of NF-kappaB activation by a dominant-negative mutant of IkappaBalpha. Mol Immunol 1996; 33: 57-61.
37. von Albertini MA, Stroka DM, Brostjan C, Stuhlmeier KM, Bach FH, Robson SC. Adenosine nucleotides induce E-selectin expression in porcine endothelial cells. Transplant Proc 1997; 29: 1062.
38. Dyck JR, Gao G, Widmer J, Stapleton D, Fernandez CS, Kemp BE et al. Regulation of 5¢-AMP-activated protein kinase activity by the noncatalytic beta and gamma subunits. J Biol Chem 1996; 271: 17798-17803.
39. Schreiber E, Matthias P, Muller MM, Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 1989; 17: 6419.
40. Chen Z, Heierhorst J, Mann RJ, Mitchelhill KI, Michell BJ, Witters LA et al. Expression of the AMP-activated protein kinase beta1 and beta2 subunits in skelet al muscle. FEBS Lett 1999; 460: 343-348.
41. Michell BJ, Stapleton D, Mitchelhill KI, House CM, Katsis F, Witters LA et al. Isoformspecific purification and substrate specificity of the 5¢-AMP-activated protein kinase. J Biol Chem 1996; 271: 28445-28450.